Aldosterone-Targeted Therapies for Uncontrolled Hypertension in Chronic Kidney Disease
June 21, 2026
In this symposium, the role of aldosterone dysregulation in the pathophysiology of cardiovascular, endocrine, and renal diseases will be explained.
CME 1.00 Credits In-Progress
Balancing Ischemic and Bleeding Risk with Antiplatelet Therapy: Personalizing Treatment to Optimize Outcomes
November 04, 2021
This program will address challenges for interventional cardiologists in using antiplatelet therapy, with the overarching focus on balancing the need to reduce ischemic risk and lower bleeding risk.
No Credit Available